Cbl family proteins: Balancing FcεRI-mediated mast cell and basophil activation

International Archives of Allergy and Immunology

Volumn 156, Issue 1, 2011, Pages 16-26

  Gasparrini, Francesca ^a   Molfetta, Rosa ^a   Santoni, Angela ^a   Paolini, Rossella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Basophils; Cbl family proteins; Fc RI; Mast cells; Negative regulation; Ubiquitination

Indexed keywords

CBL PROTEIN; FC EPSILON RECEPTOR I; FC RECEPTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

BASOPHIL; ENDOCYTOSIS; ENZYME REGULATION; HUMAN; LEUKOCYTE ACTIVATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

BASOPHILS; GENE EXPRESSION REGULATION; HUMANS; MAST CELLS; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTORS, IGE; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 84860420868     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000322236     Document Type: Review

References (84)

1. Williams CM, Galli SJ: The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000; 105: 847-859.
2. Siraganian RP: Mast cell signal transduction from the high-affinity IgE receptor. Curr Opin Immunol 2003; 15: 639-646.
3. Kraft S, Kinet JP: New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol 2007; 7: 365-378.
4. MacGlashan DW Jr: IgE receptor and signal transduction in mast cells and basophils. Curr Opin Immunol 2008; 20: 717-723.
5. Molfetta R, Peruzzi G, Santoni A, Paolini R: Negative signals from FcepsilonRI engagement attenuate mast cell functions. Arch Immunol Ther Exp (Warsz) 2007; 55: 219-229.
6. Thien CB, Langdon WY: Cbl: Many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2001; 2: 294-307.
7. Rao N, Dodge I, Band H: The Cbl family of ubiquitin ligases: Critical negative regulators of tyrosine kinase signaling in the immune system. J Leukoc Biol 2002; 71: 753-763.
8. Dikic I, Szymkiewicz I, Soubeyran P: Cbl signaling networks in the regulation of cell function. Cell Mol Life Sci 2003; 60: 1805-1827.
9. Paolini R, Molfetta R, Beitz LO, Zhang J, Scharenberg AM, Piccoli M, Frati L, Siraganian R, Santoni A: Activation of Syk tyrosine kinase is required for c-Cbl-mediated ubiquitination of FcepsilonRI and Syk in RBL cells. J Biol Chem 2002; 277: 36940-36947.
10. Kyo S, Sada K, Qu X, Maeno K, Miah SM, Kawauchi-Kamata K, Yamamura H: Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in FcepsilonRI-mediated mast cell activation. Genes Cells 2003; 8: 825-836.
11. Molfetta R, Belleudi F, Peruzzi G, Morrone S, Leone L, Dikic I, Piccoli M, Frati L, Torrisi MR, Santoni A, Paolini R: CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: A new molecular mechanism to dampen mast cell function. J Immunol 2005; 175: 4208-4216.
12. Metzger H: The receptor with high affinity for IgE. Immunol Rev 1992; 125: 37-48.
13. Donnadieu E, Jouvin MH, Kinet JP: A second amplifier function for the allergy-associated Fc(epsilon)RI-beta subunit. Immunity 2000; 12: 515-523.
14. Furuichi K, Rivera J, Isersky C: The receptor for immunoglobulin E on rat basophilic leukemia cells: Effect of ligand binding on receptor expression. Proc Natl Acad Sci USA 1985; 82: 1522-1525.
15. Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Miyajima I, Kinet JP, Galli SJ: IgE regulates mouse basophil Fc epsilon RI expression in vivo. J Immunol 1997; 158: 2517-2521.
16. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, Kinet JP, Galli SJ: IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: Evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997; 185: 663-672.
17. MacGlashan D Jr, Lichtenstein LM, McKenzie- White J, Chichester K, Henry AJ, Sutton BJ, Gould HJ: Upregulation of FcepsilonRI on human basophils by IgE antibody is mediated by interaction of IgE with FcepsilonRI. J Allergy Clin Immunol 1999; 104: 492-498.
18. Malveaux FJ, Conroy MC, Adkinson NF Jr, Lichtenstein LM: IgE receptors on human basophils: Relationship to serum IgE concentration. J Clin Invest 1978; 62: 176-181.
19. Sihra BS, Kon OM, Grant JA, Kay AB: Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: Relationship to total serum IgE concentrations. J Allergy Clin Immunol 1997; 99: 699-706.
20. Saini SS, Klion AD, Holland SM, Hamilton RG, Bochner BS, Macglashan DW Jr: The relationship between serum IgE and surface levels of FcepsilonR on human leukocytes in various diseases: Correlation of expression with FcepsilonRI on basophils but not on monocytes or eosinophils. J Allergy Clin Immunol 2000; 106: 514-520.
21. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J, Sterbinsky SA, Hamilton RG, Lichtenstein LM: Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997; 158: 1438-1445.
22. Lin S, Cicala C, Scharenberg AM, Kinet JP: The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation signals. Cell 1996; 85: 985-995.
23. Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1: 31-39.
24. Field KA, Holowka D, Baird B: Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains. J Biol Chem 1997; 272: 4276-4280.
25. Sheets ED, Holowka D, Baird B: Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcepsilonRI and their association with detergent-resistant membranes. J Cell Biol 1999; 145: 877-887.
26. Young RM, Holowka D, Baird B: A lipid raft environment enhances Lyn kinase activity by protecting the active site tyrosine from dephosphorylation. J Biol Chem 2003; 278: 20746-20752.
27. Oliver JM, Burg DL, Wilson BS, McLaughlin JL, Geahlen RL: Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J Biol Chem 1994; 269: 29697-29703.
28. Costello PS, Turner M, Walters AE, Cunningham CN, Bauer PH, Downward J, Tybulewicz VL: Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 1996; 13: 2595-2605.
29. Zhang J, Berenstein EH, Evans RL, Siraganian RP: Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syknegative variant of rat basophilic leukemia RBL-2H3 cells. J Exp Med 1996; 184: 71-79.
30. Moriya K, Rivera J, Odom S, Sakuma Y, Muramato K, Yoshiuchi T, Miyamoto M, Yamada K: ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of Fcepsilon receptor I-mediated activation of Syk. Proc Natl Acad Sci USA 1997; 94: 12539-12544.
31. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM: Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 1999; 104: 279-284.
32. Lavens-Phillips SE, MacGlashan DW Jr: The tyrosine kinases p53/56lyn and p72syk are differentially expressed at the protein level but not at the messenger RNA level in nonreleasing human basophils. Am J Respir Cell Mol Biol 2000; 23: 566-571.
33. Alvarez-Errico D, Lessmann E, Rivera J: Adapters in the organization of mast cell signaling. Immunol Rev 2009; 232: 195-217.
34. Parravicini V, Gadina M, Kovarova M, Odom S, Gonzalez-Espinosa C, Furumoto Y, Saitoh S, Samelson LE, O'Shea JJ, Rivera J: Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 2002; 3: 741-748.
35. Gibbs BF, Grabbe J: Inhibitors of PI 3-kinase and MEK kinase differentially affect mediator secretion from immunologically activated human basophils. J Leukoc Biol 1999; 65: 883-890.
36. Miura K, MacGlashan DW: Phosphatidylinositol- 3 kinase regulates p21ras activation during IgE-mediated stimulation of human basophils. Blood 2000; 96: 2199-2205.
37. Abramson J, Xu R, Pecht I: An unusual inhibitory receptor-the mast cell functionassociated antigen (MAFA). Mol Immunol 2002; 38: 1307-1313.
38. Katz HR: Inhibitory receptors and allergy. Curr Opin Immunol 2002; 14: 698-704.
39. Hitomi K, Tahara-Hanaoka S, Someya S, Fujiki A, Tada H, Sugiyama T, Shibayama S, Shibuya K, Shibuya A: An immunoglobulinlike receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions. Nat Immunol 2010; 11: 601-607.
40. Daëron M, Jaeger S, Du Pasquier L, Vivier E: Immunoreceptor tyrosine-based inhibition motifs: A quest in the past and future. Immunol Rev 2008; 224: 11-43.
41. Kepley CL, Cambier JC, Morel PA, Lujan D, Ortega E, Wilson BS, Oliver JM: Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils. J Allergy Clin Immunol 2000; 106: 337-348.
42. Kimura T, Zhang J, Sagawa K, Sakaguchi K, Appella E, Siraganian RP: Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor. J Immunol 1997; 159: 4426-4434.
43. Kimura T, Sakamoto H, Appella E, Siraganian RP: The negative signaling molecule SH2 domain-containing inositol-polyphosphate 5-phosphatase (SHIP) binds to the tyrosine- phosphorylated beta subunit of the high affinity IgE receptor. J Biol Chem 1997; 272: 13991-13996.
44. Huber M, Helgason CD, Damen JE, Liu L, Humphries RK, Krystal G: The Src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci USA 1998; 95: 11330-11335.
45. Vonakis BM, Gibbons S Jr, Sora R, Langdon JM, MacDonald SM: Src homology 2 domain- containing inositol 5+ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J Allergy Clin Immunol 2001; 108: 822-831.
46. MacGlashan DW Jr: Relationship between spleen tyrosine kinase and phosphatidylinositol 5+ phosphatase expression and secretion from human basophils in the general population. J Allergy Clin Immunol 2007; 119: 626-633.
47. Leung WH, Bolland S: The inositol 5+-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production. J Immunol 2007; 179: 95-102.
48. Furumoto Y, Brooks S, Olivera A, Takagi Y, Miyagishi M, Taira K, Casellas R, Beaven MA, Gilfillan AM, Rivera J: Cutting edge: Lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival. J Immunol 2006; 176: 5167-5171.
49. Thien CB, Langdon WY: C-Cbl and Cbl-b ubiquitin ligases: Substrate diversity and the negative regulation of signalling responses. Biochem J 2005; 391: 153-166.
50. Zheng N, Wang P, Jeffrey PD, Pavletich NP: Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 2000; 102: 533-539.
51. Joazeiro CA, Weissman AM: RING finger proteins: Mediators of ubiquitin ligase activity. Cell 2000; 102: 549-552.
52. Ciechanover A, Schwartz AL: The ubiquitinproteasome pathway: The complexity and myriad functions of proteins death. Proc Natl Acad Sci USA 1998; 95: 2727-2730.
53. Laney JD, Hochstrasser M: Substrate targeting in the ubiquitin system. Cell 1999; 97: 427-430.
54. Weissman AM: Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2001; 2: 169-178.
55. Kassenbrock CK, Anderson SM: Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. J Biol Chem 2004; 279: 28017-28027.
56. Thrower JS, Hoffman L, Rechsteiner M, Pickart CM: Recognition of the polyubiquitin proteolytic signal. EMBO J 2000; 19: 94-102.
57. Hicke L, Dunn R: Regulation of membrane protein transport by ubiquitin and ubiquitin- binding proteins. Annu Rev Cell Dev Biol 2003; 19: 141-172.
58. Haglund K, Sigismund S, Polo S, Szymkiewicz I, Di Fiore PP, Dikic I: Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat Cell Biol 2003; 5: 461-466.
59. Ota Y, Beitz LO, Scharenberg AM, Donovan JA, Kinet JP, Samelson LE: Characterization of Cbl tyrosine phosphorylation and a Cbl- Syk complex in RBL-2H3 cells. J Exp Med 1996; 184: 1713-1723.
60. Zhang J, Chiang YJ, Hodes RJ, Siraganian RP: Inactivation of c-Cbl or Cbl-b differentially affects signaling from the high affinity IgE receptor. J Immunol 2004; 173: 1811-1818.
61. Lafont F, Simons K: Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgEtriggered cell signaling. Proc Natl Acad Sci USA 2001; 98: 3180-3184.
62. Qu X, Sada K, Kyo S, Maeno K, Miah SM, Yamamura H: Negative regulation of FcepsilonRI- mediated mast cell activation by a ubiquitin-protein ligase Cbl-b. Blood 2004; 103: 1779-1786.
63. Suzuki H, Takei M, Yanagida M, Nakahata T, Kawakami T, Fukamachi H: Early and late events in Fc+ RI signal transduction in human cultured mast cells. J Immunol 1997; 159: 5881-5888.
64. Macglashan D, Miura K: Loss of syk kinase during IgE-mediated stimulation of human basophils. J Allergy Clin Immunol 2004; 114: 1317-1324.
65. Wang HY, Altman Y, Fang D, Elly C, Dai Y, Shao Y, Liu YC: Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70. J Biol Chem 2001; 276: 26004-26011.
66. Rao N, Ghosh AK, Ota S, Zhou P, Reddi AL, Hakezi K, Druker BK, Wu J, Band H: The nonreceptor tyrosine kinase Syk is a target of Cblmediated ubiquitylation upon B-cell receptor stimulation. EMBO J 2001; 20: 7085-7095.
67. Paolini R, Kinet JP: Cell surface control of the multiubiquitination and deubiquitination of high-affinity immunoglobulin E receptors. EMBO J 1993; 12: 779-786.
68. Molfetta R, Gasparrini F, Peruzzi G, Vian L, Piccoli M, Frati L, Santoni A, Paolini R: Lipid raft-dependent FcepsilonRI ubiquitination regulates receptor endocytosis through the action of ubiquitin binding adaptors. PLoS One 2009; 4:e5604.
69. Fattakhova G, Masilamani M, Borrego F, Gilfillan AM, Metcalfe DD, Coligan JE: The high-affinity immunoglobulin-E receptor (FcepsilonRI) is endocytosed by an AP-2/ clathrin-independent, dynamin-dependent mechanism. Traffic 2006; 7: 673-685.
70. Dikic I: CIN85/CMS family of adaptor molecules. FEBS Lett 2002; 529: 110-115.
71. Gustin SE, Thien CB, Langdon WY: Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells. J Immunol 2006; 177: 5980-5989.
72. Oksvold MP, Dagger SA, Thien CB, Langdon WY: The Cbl-b RING finger domain has a limited role in regulating inflammatory cytokine production by IgE-activated mast cells. Mol Immunol 2008; 45: 925-936.
73. Andoniou CE, Lill NL, Thien CB, Lupher ML Jr, Ota S, Bowtell DD, Scaife RM, Langdon WY, Band H: The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. Mol Cell Biol 2000; 20: 851-867.
74. Rao N, Miyake S, Reddi AL, Douillard P, Ghosh AK, Dodge IL, Zhou P, Fernandes ND, Band H: Negative regulation of Lck by Cbl ubiquitin ligase. Proc Natl Acad Sci USA 2002; 99: 3794-3799.
75. Sohn HW, Gu H, Pierce SK: Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk. J Exp Med 2003; 197: 1511-1524.
76. Ota Y, Samelson LE: The product of the protooncogene c-cbl: A negative regulator of the Syk tyrosine kinase. Science 1997; 276: 418-420.
77. Sada K, Zhang J, Siraganian RP: Point mutation of a tyrosine in the linker region of Syk results in a gain of function. J Immunol 2000; 164: 338-344.
78. MacGlashan DW Jr, Ishmael S, MacDonald SM, Langdon JM, Arm JP, Sloane DE: Induced loss of Syk in human basophils by non- IgE-dependent stimuli. J Immunol 2008; 180: 4208-4217.
79. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM: Multiple defects in Fc+ RI signaling in Syk-deficient nonreleaser basophils and IL-3-induced recovery of Syk expression and secretion. J Immunol 2000; 165: 5913-5920.
80. Youssef LA, Wilson BS, Oliver JM: Proteasome- dependent regulation of Syk tyrosine kinase levels in human basophils. J Allergy Clin Immunol 2002; 110: 366-373.
81. Peruzzi G, Molfetta R, Gasparrini F, Vian L, Morrone S, Piccoli M, Frati L, Santoni A, Paolini R: The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway. J Immunol 2007; 179: 2089-2096.
82. Ryan PE, Davies GC, Nau MM, Lipkowitz S: Regulating the regulator: Negative regulation of Cbl ubiquitin ligases. Trends Biochem Sci 2006; 31: 79-88.
83. Kowanetz K, Crosetto N, Haglund K, Schmidt MH, Heldin CH, Dikic I: Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. J Biol Chem 2004; 279: 32786-32795.
84. Ishmael S, MacGlashan D Jr: Early signal protein expression profiles in basophils: A population study. J Leukoc Biol 2009; 86: 313-325.